Concepts and controversies in evaluating vitamin K status in population-based studies

Nutrients

Volumn 8, Issue 1, 2016, Pages

  Kyla Shea, M ^a   Booth, Sarah L ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Biomarkers; Epidemiology; Review; Vitamin K; Vitamin K intake

Indexed keywords

BIOLOGICAL MARKER; MENAQUINONE; PHYTOMENADIONE; VITAMIN K GROUP; PROTEIN;

CIRCULATION; DIETARY INTAKE; FOOD COMPOSITION; FOOD FREQUENCY QUESTIONNAIRE; GOLD STANDARD; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BLOOD; METABOLISM; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS;

BIOMARKERS; HUMANS; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PROTEINS; VITAMIN K;

EID: 84953889097     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8010008     Document Type: Review

References (145)

1. Suttie, J.W. Vitamin K in Health and Disease; CRC Press: Boca Raton, FL, USA, 2009.
2. McCann, J.C.; Ames, B.N. Vitamin K, an example of triage theory: Is micronutrient inadequacy linked to diseases of aging? Am. J. Clin. Nutr. 2009, 90, 889-907. [CrossRef] [PubMed]
3. Willett, W.C. Nutritional Epidemiology, 3rd ed.; Oxford University Press: Oxford, UK, 2013.
4. Food and Nutrition Board Insititue of Medicne. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc; National Academy Press: Washington, DC, USA, 2002.
5. Shearer, M.J.; Fu, X.; Booth, S.L. Vitamin K nutrition, metabolism, and requirements: Current concepts and future research. Adv. Nutr. 2012, 3, 182-195. [CrossRef] [PubMed]
6. Booth, S.L.; Pennington, J.A.; Sadowski, J.A. Food sources and dietary intakes of vitamin K-1 (phylloquinone) in the American diet: Data from the FDA Total Diet Study. J. Am. Diet. Assoc. 1996, 96, 149-154. [CrossRef]
7. Duggan, P.; Cashman, K.D.; Flynn, A.; Bolton-Smith, C.; Kiely, M. Phylloquinone (vitamin K1) intakes and food sources in 18-64-year-old Irish adults. Br. J. Nutr. 2004, 92, 151-158. [CrossRef] [PubMed]
8. Erkkila, A.T.; Booth, S.L.; Hu, F.B.; Jacques, P.F.; Lichtenstein, A.H. Phylloquinone intake and risk of cardiovascular diseases in men. Nutr. Metab. Cardiovasc. Dis. 2007, 17, 58-62. [CrossRef] [PubMed]
9. Geleijnse, J.M.; Vermeer, C.; Grobbee, D.E.; Schurgers, L.J.; Knapen, M.H.; van der Meer, I.M.; Hofman, A.; Witteman, J.C. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J. Nutr. 2004, 134, 3100-3105. [PubMed]
10. Thane, C.W.; Bolton-Smith, C.; Coward, W.A. Comparative dietary intake and sources of phylloquinone (vitamin K1) among British adults in 1986-1987 and 2000-2001. Br. J. Nutr. 2006, 96, 1105-1115. [CrossRef] [PubMed]
11. Beulens, J.W.; Booth, S.L.; van den Heuvel, E.G.; Stoecklin, E.; Baka, A.; Vermeer, C. The role of menaquinones (vitamin K2) in human health. Br. J. Nutr. 2013, 110, 1357-1368. [CrossRef] [PubMed]
12. Tucker, K.L.; Smith, C.E.; Lai, C.Q.; Ordovas, J.M. Quantifying diet for nutrigenomic studies. Annu. Rev.Nutr. 2013, 33, 349-371. [CrossRef] [PubMed]
13. Barrett-Connor, E. Nutrition epidemiology: How do we know what they ate? Am. J. Clin. Nutr. 1991, 54 (Suppl. S1), 182S-187S. [CrossRef]
14. Westerterp, K.R.; Goris, A.H. Validity of the assessment of dietary intake: Problems of misreporting. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5, 489-493. [CrossRef] [PubMed]
15. Beulens, J.W.; Bots, M.L.; Atsma, F.; Bartelink, M.L.; Prokop, M.; Geleijnse, J.M.; Witteman, J.C.; Grobbee, D.E.; van der Schouw, Y.T. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 2009, 203, 489-493. [CrossRef] [PubMed]
16. Booth, S.L.; Tucker, K.L.; Chen, H.; Hannan, M.T.; Gagnon, D.R.; Cupples, L.A.; Wilson, P.W.; Ordovas, J.; Schaefer, E.J.; Dawson-Hughes, B.; et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am. J. Clin. Nutr. 2000, 71, 1201-1208. [PubMed]
17. Gast, G.C.; de Roos, N.M.; Sluijs, I.; Bots, M.L.; Beulens, J.W.; Geleijnse, J.M.; Witteman, J.C.; Grobbee, D.E.; Peeters, P.H.; van der Schouw, Y.T. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr. Metab. Cardiovasc. Dis. 2009, 19, 504-510. [CrossRef] [PubMed]
18. Nimptsch, K.; Rohrmann, S.; Linseisen, J. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am. J. Clin. Nutr. 2008, 87, 985-992. [PubMed]
19. Villines, T.C.; Hatzigeorgiou, C.; Feuerstein, I.M.; O’Malley, P.G.; Taylor, A.J. Vitamin K1 intake and coronary calcification. Coron. Artery Dis. 2005, 16, 199-203. [CrossRef] [PubMed]
20. Erkkila, A.T.; Booth, S.L.; Hu, F.B.; Jacques, P.F.; Manson, J.E.; Rexrode, K.M.; Stampfer, M.J.; Lichtenstein, A.H. Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women. Eur. J. Clin. Nutr. 2005, 59, 196-204. [CrossRef] [PubMed]
21. Booth, S.L.; Broe, K.E.; Gagnon, D.R.; Tucker, K.L.; Hannan, M.T.; McLean, R.R.; Dawson-Hughes, B.; Wilson, P.W.; Cupples, L.A.; Kiel, D.P. Vitamin K intake and bone mineral density in women and men. Am. J. Clin. Nutr. 2003, 77, 512-516. [PubMed]
22. Macdonald, H.M.; McGuigan, F.E.; Lanham-New, S.A.; Fraser, W.D.; Ralston, S.H.; Reid, D.M. Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: No evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am. J. Clin. Nutr. 2008, 87, 1513-1520. [PubMed]
23. Feskanich, D.; Weber, P.; Willett, W.C.; Rockett, H.; Booth, S.L.; Colditz, G.A.Vitamin K intake and hip fractures in women: A prospective study. Am. J. Clin. Nutr. 1999, 69, 74-79. [PubMed]
24. Chan, R.; Leung, J.; Woo, J. No association between dietary vitamin K intake and fracture risk in Chinese community-dwelling older men and women: A prospective study. Calcif. Tissue Int. 2012, 90, 396-403. [CrossRef] [PubMed]
25. Rejnmark, L.; Vestergaard, P.; Charles, P.; Hermann, A.P.; Brot, C.; Eiken, P.; Mosekilde, L. No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos. Int. 2006, 17, 1122-1132. [CrossRef] [PubMed]
26. Apalset, E.M.; Gjesdal, C.G.; Eide, G.E.; Tell, G.S. Intake of vitamin K1 and K2 and risk of hip fractures: The Hordaland Health Study. Bone 2011, 49, 990-995. [CrossRef] [PubMed]
27. Dam, V.; Dalmeijer, G.W.; Vermeer, C.; Drummen, N.E.; Knapen, M.H.; van der Schouw, Y.T.; Beulens, J.W. The association between vitamin K and the metabolic syndrome: A ten year follow-up study in adults. J. Clin. Endocrinol. Metab. 2015, 100, 2472-2479. [CrossRef] [PubMed]
28. Juanola-Falgarona, M.; Salas-Salvado, J.; Estruch, R.; Portillo, M.P.; Casas, R.; Miranda, J.; Martinez-Gonzalez, M.A.; Bullo, M. Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk. Cardiovasc. Diabetol. 2013, 12, 58-61. [CrossRef] [PubMed]
29. Shea, M.K.; Cushman, M.; Booth, S.L.; Burke, G.L.; Chen, H.; Kritchevsky, S.B. Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults. The Multi-Ethnic Study of Atherosclerosis. Thromb. Haemost. 2014, 112, 438-444. [CrossRef] [PubMed]
30. Yoshida, M.; Booth, S.L.; Meigs, J.B.; Saltzman, E.; Jacques, P.F. Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am. J. Clin. Nutr. 2008, 88, 210-215. [PubMed]
31. Nimptsch, K.; Rohrmann, S.; Kaaks, R.; Linseisen, J. Dietary vitamin K intake in relation to cancer incidence and mortality: Results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am. J. Clin. Nutr. 2010, 91, 1348-1358. [CrossRef] [PubMed]
32. Juanola-Falgarona, M.; Salas-Salvado, J.; Martinez-Gonzalez, M.A.; Corella, D.; Estruch, R.; Ros, E.; Fito, M.; Aros, F.; Gomez-Gracia, E.; Fiol, M.; et al. Dietary intake of vitamin K is inversely associated with mortality risk. J. Nutr. 2014, 144, 743-750. [CrossRef] [PubMed]
33. Cheung, C.L.; Sahni, S.; Cheung, B.M.; Sing, C.W.; Wong, I.C. Vitamin K intake and mortality in people with chronic kidney disease from NHANES III. Clin. Nutr. 2015, 34, 235-240. [CrossRef] [PubMed]
34. Geisen, C.; Watzka, M.; Sittinger, K.; Steffens, M.; Daugela, L.; Seifried, E.; Muller, C.R.; Wienker, T.F.; Oldenburg, J. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb. Haemost. 2005, 94, 773-779. [PubMed]
35. Braam, L.; McKeown, N.; Jacques, P.; Lichtenstein, A.; Vermeer, C.; Wilson, P.; Booth, S. Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring cohort. J. Am. Diet. Assoc. 2004, 104, 1410-1414. [CrossRef] [PubMed]
36. Feskanich, D.; Rimm, E.B.; Giovannucci, E.L.; Colditz, G.A.; Stampfer, M.J.; Litin, L.B.; Willett, W.C. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J. Am. Diet. Assoc. 1993, 93, 790-796. [CrossRef]
37. Presse, N.; Shatenstein, B.; Kergoat, M.J.; Ferland, G. Validation of a semi-quantitative food frequency questionnaire measuring dietary vitamin K intake in elderly people. J. Am. Diet. Assoc. 2009, 109, 1251-1255. [CrossRef] [PubMed]
38. McKeown, N.M.; Jacques, P.F.; Gundberg, C.M.; Peterson, J.W.; Tucker, K.L.; Kiel, D.P.; Wilson, P.W.; Booth, S.L. Dietary and nondietary determinants of vitamin K biochemical measures in men and women. J. Nutr. 2002, 132, 1329-1334. [PubMed]
39. Booth, S.L.; Dallal, G.; Shea, M.K.; Gundberg, C.; Peterson, J.W.; Dawson-Hughes, B. Effect of vitamin K supplementation on bone loss in elderly men and women. J. Clin. Endocrinol. Metab. 2008, 93, 1217-1223. [CrossRef] [PubMed]
40. Shea, M.K.; O’Donnell, C.J.; Hoffmann, U.; Dallal, G.E.; Dawson-Hughes, B.; Ordovas, J.M.; Price, P.A.; Williamson, M.K.; Booth, S.L. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am. J. Clin. Nutr. 2009, 89, 1799-1807. [CrossRef] [PubMed]
41. Cheung, A.M.; Tile, L.; Lee, Y.; Tomlinson, G.; Hawker, G.; Scher, J.; Hu, H.; Vieth, R.; Thompson, L.; Jamal, S.; et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): A randomized controlled trial. PLoS Med. 2008, 5, e196. [CrossRef] [PubMed]
42. Elder, S.J.; Haytowitz, D.B.; Howe, J.; Peterson, J.W.; Booth, S.L. Vitamin K contents of meat, dairy, and fast food in the U.S. Diet. J. Agric. Food. Chem. 2006, 54, 463-467. [CrossRef]
43. Manoury, E.; Jourdon, K.; Boyaval, P.; Fourcassie, P. Quantitative measurement of vitamin K2 (menaquinones) in various fermented dairy products using a reliable high-performance liquid chromatography method. J. Dairy Sci. 2013, 96, 1335-1346. [CrossRef] [PubMed]
44. Praagman, J.; Dalmeijer, G.W.; van der Schouw, Y.T.; Soedamah-Muthu, S.S.; Monique Verschuren, W.M.; Bas Bueno-de-Mesquita, H.; Geleijnse, J.M.; Beulens, J.W. The relationship between fermented food intake and mortality risk in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort. Br. J. Nutr. 2015, 113, 498-506. [CrossRef] [PubMed]
45. Sluijs, I.; Forouhi, N.G.; Beulens, J.W.; van der Schouw, Y.T.; Agnoli, C.; Arriola, L.; Balkau, B.; Barricarte, A.; Boeing, H.; Bueno-de-Mesquita, H.B.; et al. The amount and type of dairy product intake and incident type 2 diabetes: Results from the EPIC-InterAct Study. Am. J. Clin. Nutr. 2012, 96, 382-390. [CrossRef] [PubMed]
46. Aune, D.; Norat, T.; Romundstad, P.; Vatten, L.J. Dairy products and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies. Am. J. Clin. Nutr. 2013, 98, 1066-1083. [CrossRef] [PubMed]
47. Sonestedt, E.; Wirfalt, E.; Wallstrom, P.; Gullberg, B.; Orho-Melander, M.; Hedblad, B. Dairy products and its association with incidence of cardiovascular disease: The Malmo diet and cancer cohort. Eur. J. Epidemiol. 2011, 26, 609-618. [CrossRef] [PubMed]
48. Farvid, M.S.; Ding, M.; Pan, A.; Sun, Q.; Chiuve, S.E.; Steffen, L.M.; Willett, W.C.; Hu, F.B. Dietary linoleic acid and risk of coronary heart disease: A systematic review and meta-analysis of prospective cohort studies. Circulation 2014, 130, 1568-1578. [CrossRef] [PubMed]
49. Walther, B.; Karl, J.P.; Booth, S.L.; Boyaval, P. Menaquinones, bacteria, and the food supply: The relevance of dairy and fermented food products to vitamin K requirements. Adv. Nutr. 2013, 4, 463-473. [CrossRef] [PubMed]
50. Schurgers, L.J.; Vermeer, C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis 2000, 30, 298-307. [PubMed]
51. Kaneki, M.; Hodges, S.J.; Hosoi, T.; Fujiwara, S.; Lyons, A.; Crean, S.J.; Ishida, N.; Nakagawa, M.; Takechi, M.; Sano, Y.; et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: Possible implications for hip-fracture risk. Nutrition 2001, 17, 315-321. [CrossRef]
52. Hjartaker, A.; Lagiou, A.; Slimani, N.; Lund, E.; Chirlaque, M.D.; Vasilopoulou, E.; Zavitsanos, X.; Berrino, F.; Sacerdote, C.; Ocke, M.C.; et al. Consumption of dairy products in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: Data from 35,955 24-h dietary recalls in 10 European countries. Public Health Nutr. 2002, 5, 1259-1271. [CrossRef] [PubMed]
53. Thompson, F.E.; Byers, T. Dietary assessment resource manual. J. Nutr. 1994, 124 (Suppl. S11), 2245S-2317S. [PubMed]
54. Miller, T.M.; Abdel-Maksoud, M.F.; Crane, L.A.; Marcus, A.C.; Byers, T.E. Effects of social approval bias on self-reported fruit and vegetable consumption: A randomized controlled trial. Nutr. J. 2008, 7, 18588696. [CrossRef] [PubMed]
55. Potischman, N. Biologic and methodologic issues for nutritional biomarkers. J. Nutr. 2003, 133 (Suppl. S3), 875S-880S. [PubMed]
56. Blanck, H.M.; Bowman, B.A.; Cooper, G.R.; Myers, G.L.; Miller, D.T. Laboratory issues: Use of nutritional biomarkers. J. Nutr. 2003, 133 (Suppl. S3), 888S-894S. [PubMed]
57. Kawana, K.; Takahashi, M.; Hoshino, H.; Kushida, K. Circulating levels of vitamin K1, menaquinone-4, and menaquinone-7 in healthy elderly Japanese women and patients with vertebral fractures and patients with hip fractures. Endocr. Res. 2001, 27, 337-343. [CrossRef] [PubMed]
58. Tsugawa, N.; Shiraki, M.; Suhara, Y.; Kamao, M.; Tanaka, K.; Okano, T. Vitamin K status of healthy Japanese women: Age-related vitamin K requirement for gamma-carboxylation of osteocalcin. Am. J. Clin. Nutr. 2006, 83, 380-386. [PubMed]
59. Kanai, T.; Takagi, T.; Masuhiro, K.; Nakamura, M.; Iwata, M.; Saji, F. Serum vitamin K level and bone mineral density in post-menopausal women. Int. J. Gynaecol. Obstet. 1997, 56, 25-30. [CrossRef]
60. Tamatani, M.; Morimoto, S.; Nakajima, M.; Fukuo, K.; Onishi, T.; Kitano, S.; Niinobu, T.; Ogihara, T. Decreased circulating levels of vitamin K and 25-hydroxyvitamin D in osteopenic elderly men. Metabolism 1998, 47, 195-199. [CrossRef]
61. Thane, C.W.; Bates, C.J.; Shearer, M.J.; Unadkat, N.; Harrington, D.J.; Paul, A.A.; Prentice, A.; Bolton-Smith, C. Plasma phylloquinone (vitamin K1) concentration and its relationship to intake in a national sample of British elderly people. Br. J. Nutr. 2002, 87, 615-622. [CrossRef] [PubMed]
62. Thane, C.W.; Wang, L.Y.; Coward, W.A. Plasma phylloquinone (vitamin K1) concentration and its relationship to intake in British adults aged 19-64 years. Br. J. Nutr. 2006, 96, 1116-1124. [CrossRef] [PubMed]
63. Yan, L.; Zhou, B.; Greenberg, D.; Wang, L.; Nigdikar, S.; Prynne, C.; Prentice, A. Vitamin K status of older individuals in northern China is superior to that of older individuals in the UK. Br. J. Nutr. 2004, 92, 939-945. [CrossRef] [PubMed]
64. Beavan, S.R.; Prentice, A.; Stirling, D.M.; Dibba, B.; Yan, L.; Harrington, D.J.; Shearer, M.J. Ethnic differences in osteocalcin gamma-carboxylation, plasma phylloquinone (vitamin K1) and apolipoprotein E genotype. Eur. J. Clin. Nutr. 2005, 59, 72-81. [CrossRef] [PubMed]
65. Dalmeijer, G.W.; van der Schouw, Y.T.; Booth, S.L.; de Jong, P.A.; Beulens, J.W. Phylloquinone concentrations and the risk of vascular calcification in healthy women. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 1587-1590. [CrossRef] [PubMed]
66. Fusaro, M.; Noale, M.; Viola, V.; Galli, F.; Tripepi, G.; Vajente, N.; Plebani, M.; Zaninotto, M.; Guglielmi, G.; Miotto, D.; et al. Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study. J. Bone Miner. Res. 2012, 27, 2271-2278. [CrossRef] [PubMed]
67. Holden, R.M.; Morton, A.R.; Garland, J.S.; Pavlov, A.; Day, A.G.; Booth, S.L. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2010, 5, 590-597. [CrossRef] [PubMed]
68. Elliott, M.J.; Booth, S.L.; Hopman, W.M.; Holden, R.M. Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease. Can. J. Kidney Health Dis. 2014, 1. [CrossRef] [PubMed]
69. Booth, S.L.; Broe, K.E.; Peterson, J.W.; Cheng, D.M.; Dawson-Hughes, B.; Gundberg, C.M.; Cupples, L.A.; Wilson, P.W.; Kiel, D.P. Associations between vitamin K biochemical measures and bone mineral density in men and women. J. Clin. Endocrinol. Metab. 2004, 89, 4904-4909. [CrossRef] [PubMed]
70. Shea, M.K.; Booth, S.L.; Nettleton, J.A.; Burke, G.L.; Chen, H.; Kritchevsky, S.B. Circulating phylloquinone concentrations of adults in the United States differ according to race and ethnicity. J. Nutr. 2012, 142, 1060-1066. [CrossRef] [PubMed]
71. Shea, M.K.; Kritchevsky, S.B.; Hsu, F.C.; Nevitt, M.; Booth, S.L.; Kwoh, C.K.; McAlindon, T.E.; Vermeer, C.; Drummen, N.; Harris, T.B.; et al. The association between vitamin K status and knee osteoarthritis features in older adults: The Health, Aging and Body Composition Study. Osteoarthr. Cartil. 2015, 23, 370-378. [CrossRef] [PubMed]
72. Tsugawa, N.; Shiraki, M.; Suhara, Y.; Kamao, M.; Ozaki, R.; Tanaka, K.; Okano, T. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J. Bone Miner. Metab. 2008, 26, 79-85. [CrossRef] [PubMed]
73. Neogi, T.; Booth, S.L.; Zhang, Y.Q.; Jacques, P.F.; Terkeltaub, R.; Aliabadi, P.; Felson, D.T. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum. 2006, 54, 1255-1261. [CrossRef] [PubMed]
74. Misra, D.; Booth, S.L.; Tolstykh, I.; Felson, D.T.; Nevitt, M.C.; Lewis, C.E.; Torner, J.; Neogi, T. Vitamin K deficiency is associated with incident knee osteoarthritis. Am. J. Med. 2013, 126, 243-248. [CrossRef] [PubMed]
75. Shea, M.K.; Booth, S.L.; Miller, M.E.; Burke, G.L.; Chen, H.; Cushman, M.; Tracy, R.P.; Kritchevsky, S.B. Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: The Multi-Ethnic Study of Atherosclerosis. Am. J. Clin. Nutr. 2013, 98, 197-208. [CrossRef] [PubMed]
76. Card, D.J.; Shearer, M.J.; Schurgers, L.J.; Harrington, D.J. The external quality assurance of phylloquinone (vitamin K(1)) analysis in human serum. Biomed. Chromatogr. 2009, 23, 1276-1282. [CrossRef] [PubMed]
77. Lamon-Fava, S.; Sadowski, J.A.; Davidson, K.W.; O’Brien, M.E.; McNamara, J.R.; Schaefer, E.J. Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am. J. Clin. Nutr. 1998, 67, 1226-1231. [PubMed]
78. Booth, S.L.; Tucker, K.L.; McKeown, N.M.; Davidson, K.W.; Dallal, G.E.; Sadowski, J.A. Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. J. Nutr. 1997, 127, 587-592. [PubMed]
79. Booth, S.L.; O’Brien-Morse, M.E.; Dallal, G.E.; Davidson, K.W.; Gundberg, C.M. Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: Comparison of younger and older adults. Am. J. Clin. Nutr. 1999, 70, 368-377. [PubMed]
80. Novotny, J.A.; Kurilich, A.C.; Britz, S.J.; Baer, D.J.; Clevidence, B.A. Vitamin K absorption and kinetics in human subjects after consumption of 13C-labelled phylloquinone from kale. Br. J. Nutr. 2010, 104, 858-862. [CrossRef] [PubMed]
81. Jones, K.S.; Bluck, L.J.; Wang, L.Y.; Stephen, A.M.; Prynne, C.J.; Coward, W.A. The effect of different meals on the absorption of stable isotope-labelled phylloquinone. Br. J. Nutr. 2009, 102, 1195-1202. [CrossRef] [PubMed]
82. Nordestgaard, B.G.; Varbo, A. Triglycerides and cardiovascular disease. Lancet 2014, 384, 626-635. [CrossRef]
83. Booth, S.L.; Martini, L.; Peterson, J.W.; Saltzman, E.; Dallal, G.E.; Wood, R.J. Dietary phylloquinone depletion and repletion in older women. J. Nutr. 2003, 133, 2565-2569. [PubMed]
84. Shea, M.K.; Benjamin, E.J.; Dupuis, J.; Massaro, J.M.; Jacques, P.F.; D’Agostino, R.B., Sr.; Ordovas, J.M.; O’Donnell, C.J.; Dawson-Hughes, B.; et al. Genetic and non-genetic correlates of vitamins K and D. Eur. J. Clin. Nutr. 2009, 63, 458-464. [CrossRef] [PubMed]
85. Dashti, H.S.; Shea, M.K.; Smith, C.E.; Tanaka, T.; Hruby, A.; Richardson, K.; Wang, T.J.; Nalls, M.A.; Guo, X.; Liu, Y.; et al. Meta-analysis of genome-wide association studies for circulating phylloquinone concentrations. Am. J. Clin. Nutr. 2014, 100, 1462-1469. [CrossRef] [PubMed]
86. Sato, T.; Schurgers, L.J.; Uenishi, K. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr. J. 2012, 11. [CrossRef] [PubMed]
87. Karl, J.P.; Fu, X.; Dolnikowski, G.G.; Saltzman, E.; Booth, S.L. Quantification of phylloquinone and menaquinones in feces, serum, and food by high-performance liquid chromatography-mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2014, 963, 128-133. [CrossRef] [PubMed]
88. Booth, S.L.; Al, R.A. Determinants of vitamin K status in humans. Vitam. Horm. 2008, 78, 1-22. [PubMed]
89. Suttie, J.W. Vitamin K and human nutrition. J. Am. Diet. Assoc. 1992, 92, 585-590. [PubMed]
90. Limdi, N.A.; Nolin, T.D.; Booth, S.L.; Centi, A.; Marques, M.B.; Crowley, M.R.; Allon, M.; Beasley, T.M. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: A prospective cohort study. Am. J. Kidney Dis. 2015, 65, 701-709. [CrossRef] [PubMed]
91. Gundberg, C.M.; Nieman, S.D.; Abrams, S.; Rosen, H. Vitamin K status and bone health: An analysis of methods for determination of undercarboxylated osteocalcin. J. Clin. Endocrinol. Metab. 1998, 83, 3258-3266. [CrossRef] [PubMed]
92. Greenspan, S.L.; Resnick, N.M.; Parker, R.A. Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: A three-year, double-blind, placebo-controlled, randomized clinical trial. J. Clin. Endocrinol. Metab. 2005, 90, 2762-2767. [PubMed]
93. Rosen, C.J.; Chesnut, C.H.,III; Mallinak, N.J. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J. Clin. Endocrinol. Metab. 1997, 82, 1904-1910. [PubMed]
94. Rehder, D.S.; Gundberg, C.M.; Booth, S.L.; Borges, C.R. Gamma-carboxylation and fragmentation of osteocalcin in human serum defined by mass spectrometry. Mol. Cell. Proteomics 2015, 14, 1546-1555. [CrossRef] [PubMed]
95. Price, P.A.; Kaneda, Y. Vitamin K counteracts the effect of warfarin in liver but not in bone. Thromb. Res. 1987, 46, 121-131. [CrossRef]
96. Hara, K.; Kobayashi, M.; Akiyama, Y. Comparison of inhibitory effects of warfarin on gamma-carboxylation between bone and liver in rats. J. Bone Miner. Metab. 2005, 23, 366-372. [CrossRef] [PubMed]
97. Gundberg, C.M.; Lian, J.B.; Booth, S.L. Vitamin K-dependent carboxylation of osteocalcin: Friend or foe? Adv. Nutr. 2012, 3, 149-157. [CrossRef] [PubMed]
98. Theuwissen, E.; Magdeleyns, E.J.; Braam, L.A.; Teunissen, K.J.; Knapen, M.H.; Binnekamp, I.A.; van Summeren, M.J.; Vermeer, C. Vitamin K status in healthy volunteers. Food Funct. 2014, 5, 229-234. [CrossRef] [PubMed]
99. Shea, M.K.; Booth, S.L.; Gundberg, C.M.; Peterson, J.W.; Waddell, C.; Dawson-Hughes, B.; Saltzman, E. Adulthood obesity is positively associated with adipose tissue concentrations of vitamin K and inversely associated with circulating indicators of vitamin K status in men and women. J. Nutr. 2010, 140, 1029-1034. [CrossRef] [PubMed]
100. Cranenburg, E.C.; Koos, R.; Schurgers, L.J.; Magdeleyns, E.J.; Schoonbrood, T.H.; Landewe, R.B.; Brandenburg, V.M.; Bekers, O.; Vermeer, C. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb. Haemost. 2010, 104, 811-822. [PubMed]
101. Shea, M.K.; O’Donnell, C.J.; Vermeer, C.; Magdeleyns, E.J.; Crosier, M.D.; Gundberg, C.M.; Ordovas, J.M.; Kritchevsky, S.B.; Booth, S.L. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J. Nutr. 2011, 141, 1529-1534. [CrossRef] [PubMed]
102. O’Donnell, C.J.; Shea, M.K.; Price, P.A.; Gagnon, D.R.; Wilson, P.W.; Larson, M.G.; Kiel, D.P.; Hoffmann, U.; Ferencik, M.; Clouse, M.E.; et al. Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 2769-2774. [CrossRef] [PubMed]
103. Liu, G.; Peacock, M. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif. Tissue Int. 1998, 62, 286-289. [CrossRef] [PubMed]
104. Szulc, P.; Chapuy, M.C.; Meunier, P.J.; Delmas, P.D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J. Clin. Invest. 1993, 91, 1769-1774. [CrossRef] [PubMed]
105. Szulc, P.; Arlot, M.; Chapuy, M.C.; Duboeuf, F.; Meunier, P.J.; Delmas, P.D. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J. Bone Miner. Res. 1994, 9, 1591-1595. [CrossRef] [PubMed]
106. Vergnaud, P.; Garnero, P.; Meunier, P.J.; Breart, G.; Kamihagi, K.; Delmas, P.D. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS Study. J. Clin. Endocrinol. Metab. 1997, 82, 719-724. [CrossRef] [PubMed]
107. Braam, L.A.; Knapen, M.H.; Geusens, P.; Brouns, F.; Hamulyak, K.; Gerichhausen, M.J.; Vermeer, C. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif. Tissue Int. 2003, 73, 21-26. [CrossRef] [PubMed]
108. Knapen, M.H.; Drummen, N.E.; Smit, E.; Vermeer, C.; Theuwissen, E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos. Int. 2013, 24, 2499-2507. [CrossRef] [PubMed]
109. Binkley, N.; Harke, J.; Krueger, D.; Engelke, J.; Vallarta-Ast, N.; Gemar, D.; Checovich, M.; Chappell, R.; Suttie, J. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J. Bone Miner. Res. 2009, 24, 983-991. [CrossRef] [PubMed]
110. Bolton-Smith, C.; McMurdo, M.E.; Paterson, C.R.; Mole, P.A.; Harvey, J.M.; Fenton, S.T.; Prynne, C.J.; Mishra, G.D.; Shearer, M.J. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J. Bone Miner. Res. 2007, 22, 509-519. [CrossRef] [PubMed]
111. O’Connor, E.M.; Grealy, G.; McCarthy, J.; Desmond, A.; Craig, O.; Shanahan, F.; Cashman, K.D. Effect of phylloquinone (vitamin K1) supplementation for 12 months on the indices of vitamin K status and bone health in adult patients with Crohn’s disease. Br. J. Nutr. 2014, 112, 1163-1174. [CrossRef] [PubMed]
112. Emaus, N.; Gjesdal, C.G.; Almas, B.; Christensen, M.; Grimsgaard, A.S.; Berntsen, G.K.; Salomonsen, L.; Fonnebo, V. Vitamin K2 supplementation does not influence bone loss in early menopausal women: A randomised double-blind placebo-controlled trial. Osteoporos. Int. 2010, 21, 1731-1740. [CrossRef] [PubMed]
113. Ferron, M.; Hinoi, E.; Karsenty, G.; Ducy, P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. USA 2008, 105, 5266-5270. [CrossRef] [PubMed]
114. Ferron, M.; McKee, M.D.; Levine, R.L.; Ducy, P.; Karsenty, G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2012, 50, 568-575. [CrossRef] [PubMed]
115. Pollock, N.K.; Bernard, P.J.; Gower, B.A.; Gundberg, C.M.; Wenger, K.; Misra, S.; Bassali, R.W.; Davis, C.L. Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function. J. Clin. Endocrinol. Metab. 2011, 96, E1092-E1099. [CrossRef] [PubMed]
116. Prats-Puig, A.; Mas-Parareda, M.; Riera-Perez, E.; Gonzalez-Forcadell, D.; Mier, C.; Mallol-Guisset, M.; Diaz, M.; Bassols, J.; de Zegher, F.; Ibanez, L.; et al. Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diabetes Care 2010, 33, 661-663. [CrossRef] [PubMed]
117. Lu, C.; Ivaska, K.K.; Alen, M.; Wang, Q.; Tormakangas, T.; Xu, L.; Wiklund, P.; Mikkola, T.M.; Pekkala, S.; Tian, H.; Vaananen, H.K.; et al. Serum osteocalcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women. J. Clin. Endocrinol. Metab. 2012, 97, 4106-4114. [CrossRef] [PubMed]
118. Iki, M.; Tamaki, J.; Fujita, Y.; Kouda, K.; Yura, A.; Kadowaki, E.; Sato, Y.; Moon, J.S.; Tomioka, K.; Okamoto, N.; et al. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos. Int. 2012, 23, 761-770. [CrossRef] [PubMed]
119. Okuno, S.; Ishimura, E.; Tsuboniwa, N.; Norimine, K.; Yamakawa, K.; Yamakawa, T.; Shoji, S.; Mori, K.; Nishizawa, Y.; Inaba, M. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients. Osteoporos. Int. 2013, 24, 605-612. [CrossRef] [PubMed]
120. Yeap, B.B.; Alfonso, H.; Chubb, S.A.; Gauci, R.; Byrnes, E.; Beilby, J.P.; Ebeling, P.R.; Handelsman, D.J.; Allan, C.A.; Grossmann, M.; et al. Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men. J. Clin. Endocrinol. Metab. 2015, 100, 63-71. [CrossRef] [PubMed]
121. Shea, M.K.; Gundberg, C.M.; Meigs, J.B.; Dallal, G.E.; Saltzman, E.; Yoshida, M.; Jacques, P.F.; Booth, S.L. Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am. J. Clin. Nutr. 2009, 90, 1230-1235. [CrossRef] [PubMed]
122. Liu, D.M.; Guo, X.Z.; Tong, H.J.; Tao, B.; Sun, L.H.; Zhao, H.Y.; Ning, G.; Liu, J.M. Association between osteocalcin and glucose metabolism: A meta-analysis. Osteoporos. Int. 2015, 26, 2823-2833. [CrossRef] [PubMed]
123. Luo, G.; Ducy, P.; McKee, M.D.; Pinero, G.J.; Loyer, E.; Behringer, R.R.; Karsenty, G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386, 78-81. [CrossRef] [PubMed]
124. Schurgers, L.J.; Spronk, H.M.; Skepper, J.N.; Hackeng, T.M.; Shanahan, C.M.; Vermeer, C.; Weissberg, P.L.; Proudfoot, D. Post-translational modifications regulate matrix Gla protein function: Importance for inhibition of vascular smooth muscle cell calcification. J. Thromb. Haemost. 2007, 5, 2503-2511. [CrossRef] [PubMed]
125. Dalmeijer, G.W.; van der Schouw, Y.T.; Magdeleyns, E.; Ahmed, N.; Vermeer, C.; Beulens, J.W. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein. Atherosclerosis 2012, 225, 397-402. [CrossRef] [PubMed]
126. Schlieper, G.; Westenfeld, R.; Kruger, T.; Cranenburg, E.C.; Magdeleyns, E.J.; Brandenburg, V.M.; Djuric, Z.; Damjanovic, T.; Ketteler, M.; Vermeer, C.; et al. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J. Am. Soc. Nephrol. 2011, 22, 387-395. [CrossRef] [PubMed]
127. Westenfeld, R.; Krueger, T.; Schlieper, G.; Cranenburg, E.C.; Magdeleyns, E.J.; Heidenreich, S.; Holzmann, S.; Vermeer, C.; Jahnen-Dechent, W.; Ketteler, M.; et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: A randomized trial. Am. J. Kidney Dis. 2012, 59, 186-195. [CrossRef] [PubMed]
128. Dalmeijer, G.W.; van der Schouw, Y.T.; Magdeleyns, E.J.; Vermeer, C.; Verschuren, W.M.; Boer, J.M.; Beulens, J.W. Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients. Diabetes Care 2013, 36, 3766-3771. [CrossRef] [PubMed]
129. Liu, Y.P.; Gu, Y.M.; Thijs, L.; Knapen, M.H.; Salvi, E.; Citterio, L.; Petit, T.; Carpini, S.D.; Zhang, Z.; Jacobs, L.; et al. Inactive matrix Gla protein is causally related to adverse health outcomes: A Mendelian randomization study in a Flemish population. Hypertension 2015, 65, 463-470. [CrossRef] [PubMed]
130. Mayer, O., Jr.; Seidlerova, J.; Bruthans, J.; Filipovsky, J.; Timoracka, K.; Vanek, J.; Cerna, L.; Wohlfahrt, P.; Cifkova, R.; Theuwissen, E.; et al. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. Atherosclerosis 2014, 235, 162-168. [CrossRef] [PubMed]
131. Mayer, O., Jr.; Seidlerova, J.; Wohlfahrt, P.; Filipovsky, J.; Vanek, J.; Cifkova, R.; Windrichova, J.; Topolcan, O.; Knapen, M.H.; Drummen, N.E.; et al. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population. J. Hum. Hypertens. 2015. [CrossRef] [PubMed]
132. Pivin, E.; Ponte, B.; Pruijm, M.; Ackermann, D.; Guessous, I.; Ehret, G.; Liu, Y.P.; Drummen, N.E.; Knapen, M.H.; Pechere-Bertschi, A.; et al. Inactive matrix Gla-protein is associated with arterial stiffness in an adult population-based study. Hypertension 2015, 66, 85-92. [CrossRef] [PubMed]
133. Pivin, E.; Pruijm, M.; Ackermann, D.; Guessous, I.; Ehret, G.; Pechere-Bertschi, A.; Paccaud, F.; Mohaupt, M.; Vermeer, C.; Staessen, J.A.; et al. 1D.03: Inactive matrix gla protein is associated with renal resistive index in a population-based study. J. Hypertens. 2015, 33 (Suppl. S1). [CrossRef] [PubMed]
134. van den Heuvel, E.G.; van Schoor, N.M.; Lips, P.; Magdeleyns, E.J.; Deeg, D.J.; Vermeer, C.; den, H.M. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease. Maturitas 2014, 77, 137-141. [CrossRef] [PubMed]
135. Dalmeijer, G.W.; van der Schouw, Y.T.; Vermeer, C.; Magdeleyns, E.J.; Schurgers, L.J.; Beulens, J.W. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women. J. Nutr. Biochem. 2013, 24, 624-628. [CrossRef] [PubMed]
136. Dalmeijer, G.W.; van der Schouw, Y.T.; Magdeleyns, E.J.; Vermeer, C.; Verschuren, W.M.; Boer, J.M.; Beulens, J.W. Circulating desphospho-uncarboxylated matrix gamma-carboxyglutamate protein and the risk of coronary heart disease and stroke. J. Thromb. Haemost. 2014, 12, 1028-1034. [CrossRef] [PubMed]
137. Knapen, M.H.; Braam, L.A.; Drummen, N.E.; Bekers, O.; Hoeks, A.P.; Vermeer, C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: Double-blind randomised clinical trial. Thromb. Haemost. 2015, 113, 1135-1144. [CrossRef] [PubMed]
138. Farzaneh-Far, A.; Weissberg, P.L.; Proudfoot, D.; Shanahan, C.M. Transcriptional regulation of matrix gla protein. Z. Kardiol. 2001, 90 (Suppl. S3), 38-42. [CrossRef] [PubMed]
139. Mustonen, E.; Pohjolainen, V.; Aro, J.; Pikkarainen, S.; Leskinen, H.; Ruskoaho, H.; Rysa, J. Upregulation of cardiac matrix Gla protein expression in response to hypertrophic stimuli. Blood Press 2009, 18, 286-293. [CrossRef] [PubMed]
140. Price, P.A.; Thomas, G.R.; Pardini, A.W.; Figueira, W.F.; Caputo, J.M.; Williamson, M.K. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J. Biol. Chem. 2002, 277, 3926-3934. [CrossRef] [PubMed]
141. Truong, J.T.; Fu, X.; Saltzman, E.; Al, R.A.; Dallal, G.E.; Gundberg, C.M.; Booth, S.L. Age group and sex do not influence responses of vitamin K biomarkers to changes in dietary vitamin K. J. Nutr. 2012, 142, 936-941. [CrossRef] [PubMed]
142. Bugel, S.; Sorensen, A.D.; Hels, O.; Kristensen, M.; Vermeer, C.; Jakobsen, J.; Flynn, A.; Molgaard, C.; Cashman, K.D. Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women. Br. J. Nutr. 2007, 97, 373-380. [CrossRef] [PubMed]
143. Harrington, D.J.; Soper, R.; Edwards, C.; Savidge, G.F.; Hodges, S.J.; Shearer, M.J. Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J. Lipid Res. 2005, 46, 1053-1060. [CrossRef] [PubMed]
144. Al, R.A.; Peterson, J.; Choi, S.W.; Suttie, J.; Barakat, S.; Booth, S.L. Measurement of menadione in urine by HPLC. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2010, 878, 2457-2460.
145. Shea, M.K.; Booth, S.L.; Brinkley, T.E.; Kritchevsky, S.B. Vitamin K status in black and white older adults and its relationship with cardiovascular disease risk. FASEB J. 2015, 29 (Suppl. S1), 906-4.